Cancers | Free Full-Text | Low Levels of Urinary PSA Better Identify Prostate Cancer Patients
![PDF] The Effect of Cystoscopy on PSA Levels in Patients with Urologic Diseases | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/06080c014f6ab802fe6c32846350e5cfbba53484/3-Table1-1.png "PDF] The Effect of Cystoscopy on PSA Levels in Patients with Urologic Diseases | Semantic Scholar")
PDF] The Effect of Cystoscopy on PSA Levels in Patients with Urologic Diseases | Semantic Scholar
KoreaMed Synapse
Table 5.5 from Prostate Specific Antigen (PSA) growth curves: A method to improve prostate cancer screening | Semantic Scholar
Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil | Radiation Oncology | Full Text
Rates of change in PSA (ng/ml/yr) and PSA doubling time (yr) for... | Download Table
Kaplan–Meier plot of freedom from progression after salvage... | Download Scientific Diagram
Regression results of PVCR on age and PSA according to PV 0 groups | Download Scientific Diagram
Prostate-specific antigen (PSA) rate of decline post external beam radiotherapy predicts prostate cancer death - ScienceDirect
PSA Testing | ZERO Prostate Cancer
Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen | Journal of Urology
Biomedicines | Free Full-Text | Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in
Day 2,701 — PSA Test Time - Cancer Health
Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen | Journal of Urology
Cutoff value of time to prostate-specific antigen nadir is inversely correlated with disease progression in advanced prostate cancer in: Endocrine-Related Cancer Volume 19 Issue 5 (2012)
Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study
fares of changes in PSA (ng/ml/yr) and PSA doubling times (yr)for... | Download Table
Incorporating Genetic Determinants of Prostate-Specific Antigen Levels Improves Prostate Cancer Screening | medRxiv
Reevaluating PSA Testing Rates in the PLCO Trial | NEJM
